Story perspectives

UK Cuts £900M Aid to Africa, Threatening HIV Treatments

3/30/2026

Summary

Story summary

The United Kingdom has cut bilateral aid to Africa by £900 million, threatening HIV treatment and prevention.
Lenacapavir, a long-acting injectable HIV prevention drug, has shown trial success and highlights local involvement, but access remains limited.
Political decisions risk sidelining those who contributed to lenacapavir's development.
The UK faces a choice to support global health initiatives or retreat, risking lives if it withdraws funding to Unitaid, a global health organization.

1 of 1

Story summary

The United Kingdom has cut bilateral aid to Africa by £900 million, threatening HIV treatment and prevention.
Lenacapavir, a long-acting injectable HIV prevention drug, has shown trial success and highlights local involvement, but access remains limited.
Political decisions risk sidelining those who contributed to lenacapavir's development.
The UK faces a choice to support global health initiatives or retreat, risking lives if it withdraws funding to Unitaid, a global health organization.